4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-0405 |
| Compound Name: | 4-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[2-(trifluoromethyl)phenyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 482.44 |
| Molecular Formula: | C20 H17 F3 N4 O5 S |
| Smiles: | CCc1nc(CN2C(COc3ccc(cc23)S(Nc2ccccc2C(F)(F)F)(=O)=O)=O)no1 |
| Stereo: | ACHIRAL |
| logP: | 3.2502 |
| logD: | 3.2459 |
| logSw: | -3.8198 |
| Hydrogen bond acceptors count: | 10 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 96.625 |
| InChI Key: | RHPSULSTBPDODY-UHFFFAOYSA-N |